Skip header and navigation

44 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
January 14, 2022 How effective are COVID-19 vaccines? [Evergreen] INF031801v020 ESR Infectious Disease
December 26, 2021 How effective are COVID-19 vaccines? [Evergreen] INF031801v019 RR Infectious Disease
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 30, 2021 What is the evidence for the effectiveness of universal mask use in the pediatric population? EOC210901 RR EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
September 28, 2021 What is the evidence for the effectiveness of universal mask use in the pediatric population? EOC210901 ESR EOC
August 18, 2021 What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations? PH030801v2 ESR Public Health
August 17, 2021 What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? EOC012201v3 RR EOC
August 11, 2021 What are the causes of vaccine hesitancy? What programs/approaches have been successful in reducing vaccine hesitancy? EOC012201v3 ESR EOC
July 16, 2021 What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies? INF210701 ESR Infectious Disease
March 30, 2021 What are the effects of the new COVID variants on transmission and school reopenings in pediatric populations? PH030801 RR Public Health
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
March 12, 2021 What are the vaccination strategies for vulnerable populations? PH030401 RR Public Health
March 11, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001-01 ESR EOC
March 4, 2021 What are the vaccination strategies for vulnerable populations? PH030401-01 ESR Public Health
January 27, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-02 ESR Public Health
January 26, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-01 ESR Public Health
January 24, 2021 How safe are the Pfizer and Moderna vaccinations? EOC011901 RR EOC
January 21, 2021 How safe are the Pfizer and Moderna vaccinations? EOC011901-01 ESR EOC
January 19, 2021 How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models? PH011401 RR Public Health

44 records – page 1 of 3.